|
May 19
|
EDSA: Advancing EB06 for the Treatment of Vitiligo…
|
|
May 18
|
Positive Signs As Multiple Insiders Buy Edesa Biotech Stock
|
|
Mar 3
|
EDSA: Raises $15 Million to Advance EB06…
|
|
Jun 24
|
BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS
|
|
Apr 11
|
Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference
|
|
Feb 15
|
EDSA: Development of EB05 in ARDS Continues…
|
|
Jan 4
|
Edesa Biotech to Participate in Dermatology Summit and JP Morgan Week
|
|
Nov 20
|
Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study
|